  | Bastin, C.* , Bahri, M. A.* , Meyer, F., Manard, M., Delhaye, E., Plenevaux, A., Becker, G., Seret, A., Mella, C., Giacomelli, F., Degueldre, C., Balteau, E., Luxen, A., & Salmon, E. (2020). In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H Positron Emission Tomography. European Journal of Nuclear Medicine and Molecular Imaging, 47 (2), 390-402. doi:10.1007/s00259-019-04461-x  Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Bastin, C., Bahri, M. A., Meyer, F., Manard, M., Delhaye, E., Plenevaux, A., Becker, G., Seret, A., Mella, C., Giacomelli, F., Degueldre, C., Balteau, E., Luxen, A., & Salmon, E. (28 November 2018). In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H Positron Emission Tomography [Paper presentation]. Belgian Molecular Imaging Community conference 'Imaging hallmarks of disease progression & treatment response', Braine-L'Alleud, Belgium. |
  | Salmon, E., Bahri, M. A., Manard, M., Plenevaux, A., Becker, G., Seret, A., Mella, C., Aerts, J., Giacomelli, F., Luxen, A., & Bastin, C. (2017). Decreased Synaptic Density in Early Alzheimer’s Disease Assessed with [18F]UCB-H-PET. Alzheimer's and Dementia, 13 (7), 781. Peer reviewed |
 | Bahri, M. A., Stifkens, M., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Giacomelli, F., Mievis, F., Léonard, M., Seret, A., Luxen, A., ... SALMON, E. (09 May 2015). [18F]UCB-H as a new PET radiotracer for Synaptic vesicle protein 2A: A first clinical trial. Tijdschrift voor Nucleaire Geneeskunde, 37 (3), 1457-1458. Peer reviewed |
 | Bahri, M. A., Stifkens, M., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Giacomelli, F., Mievis, F., Léonard, M., Seret, A., Luxen, A., ... SALMON, E. (27 January 2015). [18F]UCB-H as a new PET radiotracer for Synaptic vesicle protein 2A: A first clinical trial [Poster presentation]. 2015 GIGA day, Liège, Belgium. |
 | WITHOFS, N., CHARLIER, E., Simoni, P., Alvarez-Miezentseva, V., Mievis, F., Giacomelli, F., Mella, C., Gambhir, S. S., Malaise, O., DE SENY, D., MALAISE, M., & HUSTINX, R. (2015). (18)F-FPRGD2 PET/CT imaging of musculoskeletal disorders. Annals of Nuclear Medicine, 29 (10), 839-47. doi:10.1007/s12149-015-1011-5 Peer Reviewed verified by ORBi |
 | Bahri, M. A., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Giacomelli, F., Mievis, F., Léonard, M., Seret, A., Luxen, A., Plenevaux, A., & Salmon, E. (06 June 2014). [18F]UCB-H AS A NEW PET RADIOTRACER FOR SYNAPTIC VESICLE PROTEIN 2A [Poster presentation]. European Molecular Imaging Meeting - EMIM 2014, Antwerp, Belgium. |
 | Bahri, M. A., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Mievis, F., Léonard, M., Seret, A., Luxen, A., Plenevaux, A., & Salmon, E. (27 May 2014). [18F]UCB-H AS A BRAIN SV2A RADIOTRACER: A FIRST CLINICAL TRIAL [Poster presentation]. XIII Turku PET Symposium, Turku, Finland. |
 | Withofs, N., Grayet, B., Tancredi, T., Rorive, A., Mella, C., Giacomelli, F., Mievis, F., Aerts, J., Waltregny, D., Jerusalem, G., & Hustinx, R. (2011). 18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers. Nuclear Medicine Communications, 32 (3), 168-176. doi:10.1097/MNM.0b013e3283412ef5 Peer Reviewed verified by ORBi |